KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Revenue, 2025
- $389M
- YoY, 2025
- +33.9%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $389M | +33.9% |
| 2024 | $291M | +473.0% |
| 2023 | $51M | — |
| 2022 | $0 | — |
| 2021 | $0 | — |
Krystal Biotech, Inc.
$322.28−3.03 (−0.93%)Close Oct 2, 2026
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $389M | +33.9% |
| 2024 | $291M | +473.0% |
| 2023 | $51M | — |
| 2022 | $0 | — |
| 2021 | $0 | — |